Developing evidence-based standards for the administration of oral anti-cancer medicines
Intended for healthcare professionals
Evidence and practice    

Developing evidence-based standards for the administration of oral anti-cancer medicines

Janice Patricia Richmond Advanced nurse practitioner, Oncology Department, Letterkenny University Hospital, Letterkenny, Republic of Ireland
Mary Grace Kelly Research nurse oncology, Letterkenny University Hospital, Letterkenny, Republic of Ireland
Patrick Jeremiah Murphy Network manager, Health Research Board Centre for Primary Care Research, Galway, Republic of Ireland
Andrew William Murphy Director, Health Research Board Centre for Primary Care Research, Galway, Republic of Ireland
Alison Johnston Clinical nurse manager information technology and data management, Letterkenny University Hospital, Letterkenny, Republic of Ireland

Why you should read this article:
  • To enhance your knowledge of the safe administration of oral anti-cancer medicines

  • To appreciate the importance of monitoring patients taking oral anti-cancer medicines

  • To read about the development of new standards for the administration of oral anti-cancer medicines

Cancer treatments have undergone a paradigm shift with the development and rapid growth of the use of oral anti-cancer treatment, particularly within the past ten years. Responsibility for administration of oral anti-cancer medicines has largely been devolved from the oncology team to the patient and their caregivers. However, there are longstanding safety concerns about people receiving oral anti-cancer medicines, therefore patient management and safety is of paramount importance. The authors reviewed the evidence and guidelines on administration of oral anti-cancer medicines, which encompasses patient management, then formulated new standards for clinical practice, which are reported in the article.

Cancer Nursing Practice. doi: 10.7748/cnp.2022.e1828

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Correspondence

janicep.richmond@hse.ie

Conflict of interest

This work was supported by the Irish Cancer Society (Grant number CNRA19RIC) in partnership with the Health Research Board, the National Cancer Control Programme and the Office of the Nursing and Midwifery Services Director. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript

Richmond JP, Kelly MG, Murphy PJ et al (2022) Developing evidence-based standards for the administration of oral anti-cancer medicines. Cancer Nursing Practice. doi: 10.7748/cnp.2022.e1828

Published online: 24 November 2022

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or